Рет қаралды 4,144
Dr. Gervasio Lamas is the Principal Investigator and Chair of the Trials to Access Chelation Therapy (TACT). After the initial 10-year TACT study, Dr. Lamas found extraordinary results, particularly relating to diabetic patients.
With such promising results, he was then asked to continue his studies through TACT 2, which is currently collecting data, and the upcoming TACT 3A.
This fascinating update shows an exciting look at the future of Chelation Therapy!
Want to get involved? Contact Dr. Lamas at gervasiolamas@gmail.com or by calling 305-674-2162.
Video Links-
TACT Website: tact2.org
TACT Publications: tact2.org/publications
National Institutes of Health: nih.gov
Mount Sinai Center: msmc.com/cardiology
Become certified in Chelation Therapy: acam.org/CAP
Find a Chelation certified practitioner: acam.org/membermap